Joseph Michael Fitzgerald, EVP & Group President, Cardiology at BOSTON SCIENTIFIC CORP (BSX), sold 126,678 shares at $53.60 ($6.8M) on 2023-05-16, disclosed to the SEC on 2023-05-17.
Open-market sale of $6.8M BSX by EVP & Group President, Cardiology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.60 | 63,339 | $3.4M | 50.0% |
| 2 | $53.60 | 63,339 | $3.4M | 50.0% |
| Total | $53.60 avg | 126,678 | $6.8M | 100% |
| Filing → |
| BSX | SELL | 2025-09-03 | $10.5M | — | Filing → |
| BSX | SELL | 2025-08-04 | $5.2M | — | Filing → |
| BSX | SELL | 2025-07-02 | $5.3M | — | Filing → |